Privia Health Group Inc

Aktienanalyse zu Privia Health Group Inc (PRVA)

$22.520

-0.099 (-0.44%)Zum Schluss

Loading chart…
Hoch
22.800
Eröffnung
22.670
Volumengewichteter Durchschnittskurs
22.57
Volumen
1.25M
Marktkap.
2.04B
Tief
22.395
Umsatz
28.16M
EV/EBITDA, TTM
-6,436.55

Privia Health Group, Inc. is a technology-driven, national physician-enablement company. The Company collaborates with medical groups, health plans and health systems. It enhances physician practices, improves patient experiences and doctors for delivering care in both in-person and virtual care settings. Its Privia Platform is powered by the Privia Technology Solution, an end-to-end, cloud-based technology solution that integrates both Privia-developed and third-party applications into an interface and workflow that manages all aspects of its Privia Providers provision of healthcare services. Privia Platform optimizes provider workflow across the full continuum of reimbursement arrangements. The Company provides management services to each Medical Group though a local management services organization, which provides Medical Groups with access to value-based care (VBC) opportunities either directly or through Privia-owned accountable care organizations.

KI-Analyse of Privia Health Group Inc (PRVA)

Kaufen

Privia Health Group Inc is a good buy right now, trading at $22.52 with a strong RSI of 86.73 indicating overbought conditions, but also reflecting strong momentum. The company reported a significant 12.4% year-over-year increase in practice collections to $970 million in Q2 2026, and raised its financial outlook for the year, which is a positive indicator for future growth. However, the main risk is the recent earnings surprise of -12.5%, which may affect investor sentiment.

Bewertungskennzahlen

Das aktuelle erwartete KGV von Privia Health Group Inc (PRVA) beträgt 17.27, verglichen mit dem 5-Jahres-Durchschnitt von 59.29.

Erwartetes KGV

Fair bewertet
5J-Durchschnitt P/E
59.29
Aktuelles P/E
17.27
Überbewertet
343.79
Unterbewertet
-225.21

Erwartetes EV/EBITDA

Stark unterbewertet
5J-Durchschnitt EV/EBITDA
-119.70
Aktuelles EV/EBITDA
-6436.55
Überbewertet
1010.94
Unterbewertet
-1250.34

Erwartetes KUV

Unterbewertet
5J-Durchschnitt P/S
1.61
Aktuelles P/S
1.07
Überbewertet
2.11
Unterbewertet
1.11

Alphio-AI-Kursszenarien für PRVA

Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

B

Bullisch

Bullisch · 25%PRVA

$29.18

Szenariopreis

B

Basis

Basis · 50%PRVA

$27.83

Szenariopreis

B

Bärisch

Bärisch · 25%PRVA

$24.83

Szenariopreis

Whales, die PRVA halten

R

Riverbridge Partners, LLC

+ HältPRVA

+4.04%

3-Monats-Rendite

D

Durable Capital Partners, LP

+ HältPRVA

-5.68%

3-Monats-Rendite

Event-Zeitleiste

2026-08-06 (ET)

06:30:00

FY26 Consensus at $2.42, Adjusted EBITDA Expected in $145M-$155M Range

06:30:00

Company Reports Q2 Revenue of $632.6M

2026-05-27 (ET)

09:10:00

Privia Health Signs Agreement with NGBC to Enter New Jersey

2026-05-07 (ET)

06:20:00

Company Reports Q1 Revenue of $603.8M, Exceeds Consensus

2026-02-26 (ET)

06:30:00

Expects Approximately $600M in Cash by Year-End 2026

News

PRVA FAQ – beantwortet von Alphio AI

Privia Health Group, Inc. is a technology-driven, national physician-enablement company. The Company collaborates with medical groups, health plans and health systems. It enhances physician practices, improves patient experiences and doctors for delivering care in both in-person and virtual care settings. Its Privia Platform is powered by the Privia Technology Solution, an end-to-end, cloud-based technology solution that integrates both Privia-developed and third-party applications into an interface and workflow that manages all aspects of its Privia Providers provision of healthcare services. Privia Platform optimizes provider workflow across the full continuum of reimbursement arrangements. The Company provides management services to each Medical Group though a local management services organization, which provides Medical Groups with access to value-based care (VBC) opportunities either directly or through Privia-owned accountable care organizations. It operates in the Healthcare sector (SERVICES-HEALTH SERVICES industry).

Privia Health Group Inc is a good buy right now, trading at $22.52 with a strong RSI of 86.73 indicating overbought conditions, but also reflecting strong momentum. The company reported a significant 12.4% year-over-year increase in practice collections to $970 million in Q2 2026, and raised its financial outlook for the year, which is a positive indicator for future growth. However, the main risk is the recent earnings surprise of -12.5%, which may affect investor sentiment.

Community

Mehr ↗

Noch keine Beiträge

Registriere dich oder melde dich an, um mitzudiskutieren

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln